Grove’s pill for U.S. healthcare won’t work
Having survived prostate cancer and now facing a mild form of Parkinson’s disease, former Intel chairman Andy Grove has turned his analytical eye on the increasingly dysfunctional U.S. healthcare system.
Grove is a smart guy, however his recommendations are disappointingly small-scale and reflective of the inordinate faith that many high-tech aficionados place in technological “fixes” for complex phenomena. That’s what David Hamilton, writer of VentureBeat Life Sciences argues in his latest look at the healthcare debate.
Note… Continue Reading
Andy Grove’s placebo pill for U.S. healthcare
Having survived prostate cancer and now facing a mild form of Parkinson’s disease, former Intel chairman Andy Grove has turned his analytical eye on the increasingly dysfunctional U.S. healthcare system.
Unfortunately, his recommendations are disappointingly small-scale and reflective of the inordinate faith that many high-tech aficionados place in technological “fixes” for complex social phenomena. I’ll explain why in a moment.
To Grove’s tremendous credit, he argues in a recent interview with Wired News that the most pressing… Continue Reading